| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.17 | 0.0003 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.21 | 0.0004 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.21 | 0.0004 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |